-
-
-
-
-
-
-
Catalyst Pharmaceuticals (CPRX) 3600 contracts of May 30 calls trade, share price up 7.9%
-
-
-
-
-
-
-
Catalyst Pharmaceuticals settles FIRDAPSE patent dispute with Lupin
-
-
-
-
-
-
-
Catalyst Pharmaceutical Partners (CPRX) PT Raised to $40 at Stephens
-
-
-
-
-
-
-
Citi Catalyst Pharmaceutical (CPRX): 'Firdapse Patent Litigation Settlement with Teva Meaningfully Derisks LOE Overhang on Shares'
-
-
-
-
-
-
-
Catalyst Pharmaceutical Partners (CPRX) PT Raised to $31 at Citi
-
-
-
-
413,279 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

